Our innovative DNA platforms instruct the body’s immune system to create potent responses when and where they’re needed.
Today, we’re focusing our TheraPlas® platform on ovarian cancer and validating our PlaCCine platform via the SARS-CoV-2 virus, and we envision a future where these technologies fight a range of cancers and infectious diseases.
We are scientists, researchers, and innovators who believe in the power of immunology and DNA as the building block for health and well-being, and we’re just getting started.
